OBJECTIVE: Clinical guidelines recommend that antidepressant treatment should be continued for a minimum of 6 months following response in depression and anxiety disorders. However, adherence to antidepressants is low. This prospective cohort study investigated the influence of patients' antidepressant concerns, treatment preferences, and illness perceptions on adherence to antidepressants over a 6-month period. METHOD: A cohort of 178 patients aged 18 to 74 years and newly issued with a prescription for antidepressants to treat any condition was followed up prospectively at 5 primary care practices in Southeast England. Adherence was measured through self-report and prescription refill data. Patient perceptions were quantified using validated outcome measures, the Beliefs about Medicine Questionnaire and the Illness Perception Questionnaire, at 4 timepoints. Patient treatment preferences were recorded using a specially designed questionnaire. Data collection took place between September 2000 and May 2002. RESULTS: Of 147 participants (83%) who completed the study, 19% persisted with antidepressants in accordance with guideline recommendations throughout the 6-month period. Specific concern about antidepressant side effects (OR = 3.30, 95% CI = 2.20 to 4.97) and general worry about taking antidepressants (OR = 1.65, 95% CI = 1.13 to 2.40) were independent predictors of antidepressant nonuse. Preference for different treatment/uncertainty about preferred treatment was also a strong predictor (OR = 3.82, 95% CI = 1.35 to 10.77). However, illness perceptions were not associated with adherence. CONCLUSIONS: Concerns about antidepressants and a mismatch between patients' preferred and prescribed treatment act as significant barriers to sustained adherence. This study highlights the central role of the patient-physician partnership in exploring antidepressant concerns, working with treatment preferences, and providing supportive continued management. The findings may inform the development of interventions within primary care programs to enhance commitment to treatment for common mental disorders.
OBJECTIVE: Clinical guidelines recommend that antidepressant treatment should be continued for a minimum of 6 months following response in depression and anxiety disorders. However, adherence to antidepressants is low. This prospective cohort study investigated the influence of patients' antidepressant concerns, treatment preferences, and illness perceptions on adherence to antidepressants over a 6-month period. METHOD: A cohort of 178 patients aged 18 to 74 years and newly issued with a prescription for antidepressants to treat any condition was followed up prospectively at 5 primary care practices in Southeast England. Adherence was measured through self-report and prescription refill data. Patient perceptions were quantified using validated outcome measures, the Beliefs about Medicine Questionnaire and the Illness Perception Questionnaire, at 4 timepoints. Patient treatment preferences were recorded using a specially designed questionnaire. Data collection took place between September 2000 and May 2002. RESULTS: Of 147 participants (83%) who completed the study, 19% persisted with antidepressants in accordance with guideline recommendations throughout the 6-month period. Specific concern about antidepressant side effects (OR = 3.30, 95% CI = 2.20 to 4.97) and general worry about taking antidepressants (OR = 1.65, 95% CI = 1.13 to 2.40) were independent predictors of antidepressant nonuse. Preference for different treatment/uncertainty about preferred treatment was also a strong predictor (OR = 3.82, 95% CI = 1.35 to 10.77). However, illness perceptions were not associated with adherence. CONCLUSIONS: Concerns about antidepressants and a mismatch between patients' preferred and prescribed treatment act as significant barriers to sustained adherence. This study highlights the central role of the patient-physician partnership in exploring antidepressant concerns, working with treatment preferences, and providing supportive continued management. The findings may inform the development of interventions within primary care programs to enhance commitment to treatment for common mental disorders.
Authors: Charlotte Brown; Deena R Battista; Richard Bruehlman; Susan S Sereika; Michael E Thase; Jacqueline Dunbar-Jacob Journal: Med Care Date: 2005-12 Impact factor: 2.983
Authors: Scott A Bull; Enid M Hunkeler; Janelle Y Lee; Clayton R Rowland; Todd E Williamson; Joseph R Schwab; Stephen W Hurt Journal: Ann Pharmacother Date: 2002-04 Impact factor: 3.154
Authors: Mark D Sullivan; Wayne J Katon; Joan E Russo; Ellen Frank; James E Barrett; Thomas E Oxman; John W Williams Journal: J Am Board Fam Pract Date: 2003 Jan-Feb
Authors: Scott A Bull; X Henry Hu; Enid M Hunkeler; Janelle Y Lee; Eileen E Ming; Leona E Markson; Bruce Fireman Journal: JAMA Date: 2002-09-18 Impact factor: 56.272
Authors: Elizabeth H B Lin; Michael Von Korff; Evette J Ludman; Carolyn Rutter; Terry M Bush; Gregory E Simon; Jürgen Unützer; Edward Walker; Wayne J Katon Journal: Gen Hosp Psychiatry Date: 2003 Sep-Oct Impact factor: 3.238
Authors: Digna J F van Schaik; Alexandra F J Klijn; Hein P J van Hout; Harm W J van Marwijk; Aartjan T F Beekman; Marten de Haan; Richard van Dyck Journal: Gen Hosp Psychiatry Date: 2004 May-Jun Impact factor: 3.238
Authors: Jesús López-Torres Hidalgo; Yolanda López Gallardo; Ignacio Párraga Martínez; José María Del Campo Del Campo; Alejandro Villena Ferrer; Susana Morena Rayo Journal: Community Ment Health J Date: 2015-04-02
Authors: Amir Krivoy; Ran D Balicer; Becca Feldman; Moshe Hoshen; Gil Zalsman; Abraham Weizman; Gal Shoval Journal: Psychopharmacology (Berl) Date: 2015-06-21 Impact factor: 4.530